PTH and hypophosphatemia: This clinical concern is exacerbated by the lack of consensus on if or how to treat FGF23-mediated hypophosphatemia, as treatment with phosphate supplementation can be counterproductive due to increased parathyroid hormone that may worsen FGF23-mediated urinary phosphate excretion.